The hearing aid market in France operates under a precise regulatory framework since the implementation of the 100% Health system. This framework structures the prices, reimbursement levels, and trial conditions offered by brands like Audika. Understanding these mechanisms allows one to distinguish between the displayed price, the actual out-of-pocket expense, and the plans presented as “no commitment.”
Class 1 and Class 2: What the regulated price changes for out-of-pocket expenses
The distinction between Class 1 and Class 2 devices determines the entire financial calculation. Devices in Class 1 are capped at 950 euros per ear in France. With a responsible mutual insurance or the Complementary Health Solidarity (CSS), the coverage can be complete, meaning zero out-of-pocket expense for the user.
Class 2 devices are not subject to this cap. The average out-of-pocket expense ranges between 600 and 1,000 euros per ear depending on the level of complementary guarantees. In other words, choosing a high-end model at Audika or elsewhere involves a significant personal budget, even with good insurance.
This mechanism is often summarized by brands with the phrase “devices from 0 euros.” The statement is technically accurate for Class 1, but it hides a prerequisite: one must have a mutual insurance contract that effectively covers the difference between the Social Security base and the capped price. Those who detail the prices of hearing aids at Audika find that this nuance is rarely highlighted in commercial communication.
30-day trial without commitment: an industry standard, not an exclusive advantage
Audika offers a free 30-day trial, presented as a distinctive asset. In practice, this formula has become widespread across the sector. Most competing brands (Alliance Audition, Amplifon, Optical Center Audition) offer comparable trial periods, driven by competition and the 100% Health framework.
The initial hearing assessment is also free at Audika, but it is a non-medical assessment. It does not replace an ENT consultation or an audiogram prescribed by a doctor. A medical prescription remains mandatory for any provision of hearing aids.
What the term “no commitment” concretely covers:
- The user can return the devices at the end of the trial period with no obligation to purchase, except for possible custom ear tip fees according to the center’s conditions
- The trial covers the entire range, including Class 2 models, allowing for comparison of comfort between entry-level and high-end
- The audiologist’s follow-up during the trial is included, with gradual adjustments to adapt amplification to the user’s daily environment
The potential trap lies in the transition from trial to purchase. Once accustomed to a Class 2 model, reverting to a Class 1 device (capped and fully reimbursed) may seem like a step back in terms of sound comfort. The no-commitment trial sometimes leads to a choice that is more expensive than what the initial budget anticipated.
Installment payment and financing: a lever that changes the perception of price
Most audiologists, including Audika, offer interest-free installment payments, in three installments or more. This practice, nearly universal in 2026, transforms how the price is perceived compared to a one-time purchase.
A Class 2 device listed with several hundred euros of out-of-pocket expense per ear seems more accessible when the amount is spread over several months. The total cost remains the same, but the psychological barrier decreases. For individuals with modest incomes, this payment ease does not resolve the underlying issue if the insurance only covers a small part of the free price.
Some points to check before committing to financing:
- Confirm that the installment plan is truly interest-free (no hidden interest rates or processing fees)
- Request a standardized quote detailing the price of the device, the cost of follow-up services, and the amount reimbursed by Social Security and the mutual insurance
- Ensure that the follow-up over the device’s lifespan (minimum four years) is included in the overall price and not charged separately
Audika and the choice of audiologist: criteria beyond the catalog price
Comparing prices between brands solely based on the displayed price gives an incomplete picture. The price of a hearing aid at an audiologist includes adjustment sessions, regular follow-up, and adjustments over several years. The quality of the audiologist’s follow-up weighs as much as the chosen model in long-term satisfaction.
Audika has a dense network of hearing centers in France, which facilitates local follow-up. However, the density of the network does not guarantee the availability of the same audiologist from one visit to another, a point that can affect the continuity of adjustments.
The available data do not allow for a conclusion that one brand systematically offers a better value for money than another. Field feedback varies on this point, as satisfaction largely depends on the relationship with the professional providing follow-up, the severity of hearing loss, and the user’s expectations regarding discretion or connectivity.
The choice between a fully reimbursed Class 1 device and a Class 2 model with high out-of-pocket expenses remains an individual decision. Price should not be the only criterion: daily auditory comfort and the regularity of follow-up determine the actual effectiveness of the hearing aid. Requesting a standardized quote from several brands, including Audika, before committing remains the most reliable approach to assess the real cost, beyond marketing promises.